Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Med. oral patol. oral cir. bucal (Internet) ; 11(2): E136-E140, mar.-abr. 2006. ilus
Artigo em En | IBECS | ID: ibc-045794

RESUMO

No disponible


Rhabdomyosarcoma (RMS) is a malignant soft tissue neoplasm consisting of cells derived from the primitive mesenchyme that exhibit a profound tendency to myogenesis. About 35% of RMS arises in the head and neck, being classified as parameningeal and non-orbital non-parameningeal forms. Parameningeal tumors carry the worst prognosis. The use of contemporary, multi-agent chemotherapy, radiotherapy, and surgery has made treatment of the disseminated disease possible, and has significantly improved overall survival from 25% in 1970 to 70% in 1991. Here, we present the management of two cases of orofacial RMS in adolescents: an 18-year-old, white female that had a 9-month history of a nodule in the left buccal mucosa, and a 19-year-old, white male who had been aware of a nodule in the left, posterior maxillary ridge with progressive growth for 4 months. Before final diagnosis, both cases were previously treated as inflammatory lesions. Their clinicopathological aspects, treatment, and poor survival as a consequence of delays in diagnosis are discussed


Assuntos
Masculino , Feminino , Adulto , Adolescente , Humanos , Rabdomiossarcoma/diagnóstico , Rabdomiossarcoma/terapia , Neoplasias Bucais/diagnóstico , Neoplasias Bucais/terapia , Evolução Fatal
2.
Med Oral Patol Oral Cir Bucal ; 11(2): E136-40, 2006 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-16505791

RESUMO

Rhabdomyosarcoma (RMS) is a malignant soft tissue neoplasm consisting of cells derived from the primitive mesenchyme that exhibit a profound tendency to myogenesis. About 35% of RMS arises in the head and neck, being classified as parameningeal and non-orbital non-parameningeal forms. Parameningeal tumors carry the worst prognosis. The use of contemporary, multi-agent chemotherapy, radiotherapy, and surgery has made treatment of the disseminated disease possible, and has significantly improved overall survival from 25% in 1970 to 70% in 1991. Here, we present the management of two cases of orofacial RMS in adolescents: an 18-year-old, white female that had a 9-month history of a nodule in the left buccal mucosa, and a 19-year-old, white male who had been aware of a nodule in the left, posterior maxillary ridge with progressive growth for 4 months. Before final diagnosis, both cases were previously treated as inflammatory lesions. Their clinicopathological aspects, treatment, and poor survival as a consequence of delays in diagnosis are discussed.


Assuntos
Neoplasias Bucais , Rabdomiossarcoma , Adolescente , Adulto , Evolução Fatal , Feminino , Humanos , Masculino , Neoplasias Bucais/diagnóstico , Neoplasias Bucais/terapia , Rabdomiossarcoma/diagnóstico , Rabdomiossarcoma/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...